Shanxi Medical University Researchers Add New Study Findings to Research in Colon Cancer (Synaptotagmin 1 Suppresses Colorectal Cancer Metastasis by Inhibiting ERK/MAPK Signaling-Mediated Tumor Cell Pseudopodial Formation and Migration).

A recent study conducted by researchers at Shanxi Medical University in China explored the role of synaptotagmin 1 (SYT1) in colorectal cancer (CRC) metastasis. The study found that SYT1 expression was lower in CRC tissues and cell lines compared to normal colorectal tissues and cell lines. Overexpression of SYT1 inhibited pseudopodial formation, cell migration, invasion, and metastasis in CRC cells. The study suggests that SYT1 may serve as a therapeutic target for CRC. Further details of the study can be found in the article "Synaptotagmin 1 Suppresses Colorectal Cancer Metastasis by Inhibiting ERK/MAPK Signaling-Mediated Tumor Cell Pseudopodial Formation and Migration" published in the journal Cancers. [Extracted from the article]

Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)